- Home
- XERS
XERS
Xeris Biopharma Holdings Inc.
as 04-18-2025 1:45pm EST
| Founded: | 2005 | Country: | United States |
| Employees: | N/A | City: | CHICAGO |
| Market Cap: | N/A | IPO Year: | 2018 |
| Target Price: | $6.10 | AVG Volume (30 days): | 3.8M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.37 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.69 - $6.07 | Next Earning Date: | 05-08-2025 |
| Revenue: | $203,070,000 | Revenue Growth: | 23.89% |
| Revenue Growth (this year): | 31.75% | Revenue Growth (next year): | 21.09% |
Stock Insider Trading Activity of Xeris Biopharma Holdings Inc. (XERS)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Hecht Beth | XERS | See Remarks | Mar 20 '25 | Sell | $5.43 | 40,000 | $217,244.00 | 1,353,510 |
Latest Xeris Biopharma Holdings Inc. News
XERS Breaking Stock News: Dive into XERS Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 days ago
Bright Peak Therapeutics Appoints John Schmid to its Board of Directors
Business Wire
22 days ago
Xeris Announces Changes to Its Board of Directors
Insider Monkey
23 days ago
Is Xeris Biopharma Holdings (XERS) The Hot Biotech Stock Under $5?
Zacks
a month ago
Strength Seen in Xeris Biopharma (XERS): Can Its 5.6% Jump Turn into More Strength?
Insider Monkey
a month ago
Xeris Biopharma Holdings (XERS): Among the Best Stocks to Invest in for a Stock Market Game
Simply Wall St.
a month ago
Calculating The Fair Value Of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)
MT Newswires
a month ago
Xeris Biopharma Says US FDA Approves Gvoke VialDx for Diagnostic Use
Business Wire
a month ago
Xeris Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke VialDx™ (glucagon) for Use as a Diagnostic Aid
Compare XERS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "XERS Xeris Biopharma Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.